Squarepoint’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-91,846
Closed -$188K 4421
2025
Q4
$188K Buy
91,846
+29,773
+48% +$86K ﹤0.01% 3894
2025
Q3
$215K Buy
+62,073
New +$173K ﹤0.01% 3890
2025
Q1
Sell
-189,462
Closed -$241K 4782
2024
Q4
$241K Buy
189,462
+96,749
+104% +$247K ﹤0.01% 4328
2024
Q3
$316K Sell
92,713
-601,467
-87% -$2.62M ﹤0.01% 3406
2024
Q2
$3.24M Sell
694,180
-204,276
-23% -$1.15M 0.01% 1684
2024
Q1
$6.67M Buy
898,456
+316,678
+54% +$2.63M 0.01% 1253
2023
Q4
$5.89M Buy
581,778
+35,021
+6% +$307K 0.01% 1292
2023
Q3
$4.26M Buy
546,757
+487,094
+816% +$4.18M 0.01% 1285
2023
Q2
$491K Buy
+59,663
New +$520K ﹤0.01% 2631
2023
Q1
Sell
-33,444
Closed -$297K 3351
2022
Q4
$297K Sell
33,444
-3,078
-8% -$33.8K ﹤0.01% 2586
2022
Q3
$447K Buy
+36,522
New +$569K ﹤0.01% 2255
2022
Q1
Sell
-36,806
Closed -$977K 3005
2021
Q4
$977K Buy
36,806
+20,332
+123% +$700K ﹤0.01% 1714
2021
Q3
$677K Buy
+16,474
New +$903K ﹤0.01% 1794
2021
Q1
Sell
-4,020
Closed -$282K 3233
2020
Q4
$282K Sell
4,020
-18,259
-82% -$750K ﹤0.01% 2252
2020
Q3
$625K Buy
22,279
+13,977
+168% +$455K 0.01% 1259
2020
Q2
$246K Buy
+8,302
New +$217K ﹤0.01% 1718
2020
Q1
Sell
-8,573
Closed -$254K 2012
2019
Q4
$254K Buy
+8,573
New +$214K ﹤0.01% 2122
2019
Q3
Sell
-16,100
Closed -$398K 2413
2019
Q2
$398K Sell
16,100
-80,400
-83% -$1.92M ﹤0.01% 1789
2019
Q1
$2.36M Buy
96,500
+12,181
+14% +$276K 0.03% 710
2018
Q4
$1.92M Buy
84,319
+28,019
+50% +$763K 0.02% 691
2018
Q3
$1.79M Buy
56,300
+4,638
+9% +$150K 0.02% 766
2018
Q2
$1.85M Buy
51,662
+25,862
+100% +$916K 0.02% 661
2018
Q1
$855K Buy
25,800
+11,879
+85% +$423K 0.01% 866
2017
Q4
$428K Buy
+13,921
New +$351K 0.01% 1301
2017
Q2
Sell
-9,698
Closed -$216K 1583
2017
Q1
$216K Sell
9,698
-10,328
-52% -$214K 0.01% 1255
2016
Q4
$325K Buy
+20,026
New +$304K 0.01% 1107
2016
Q3
Sell
-15,400
Closed -$376K 1071
2016
Q2
$376K Buy
+15,400
New +$519K 0.02% 647

Other funds holding EDIT